Esperion Therapeutics
ESPR
$1.90
Share price
-4.52%
Change (1 day)
52.00%
Change (1 year)
Categories
EPS for Esperion Therapeutics (ESPR)
EPS in 2023 (TTM): -$2.82
According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.82. In 2022 the company made an earnings per share (EPS) of -$3.55 an increase over its 2021 EPS that were of -$9.56.
EPS history for Esperion Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.82 | -20.56% |
| 2022 | -$3.55 | -62.87% |
| 2021 | -$9.56 | 80.38% |
| 2020 | -$5.30 | 50.14% |
| 2019 | -$3.53 | -53.18% |
| 2018 | -$7.54 | 7.41% |
| 2017 | -$7.02 | 110.81% |
| 2016 | -$3.33 | 47.35% |
| 2015 | -$2.26 | 0.89% |
| 2014 | -$2.24 | 28.84% |
| 2013 | -$1.74 | -89.3% |
| 2012 | -$16.25 | |
| 2002 | -$6.85 | 8.89% |
| 2001 | -$6.29 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $1.86 | -165.96% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $37.36 | -1,424.82% | 🇺🇸 USA |
 Ultragenyx RARE | -$10.24 | 263.12% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -$0.68 | -75.89% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | -$0.64 | -77.30% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $0.78 | -127.61% | 🇺🇸 USA |